Group 1 - The core viewpoint of the news is that Dabo Medical's stock has increased by 5%, reaching a price of 58.80 CNY per share, with a trading volume of 204 million CNY and a turnover rate of 1.22%, resulting in a total market capitalization of 24.344 billion CNY [1] - Dabo Medical Technology Co., Ltd. is located in Xiamen, Fujian Province, established on August 12, 2004, and listed on September 22, 2017. The company specializes in the production, research, and sales of high-value medical consumables [1] - The main business revenue composition includes trauma products (38.68%), spinal products (17.95%), minimally invasive surgical products (16.34%), joint products (10.37%), other products (9.27%), neurosurgery products (4.50%), and dental products (2.89%) [1] Group 2 - From the perspective of Dabo Medical's top ten circulating shareholders, a fund under Southern Fund ranks among them. The Southern CSI 1000 ETF (512100) increased its holdings by 141,900 shares in the second quarter, holding a total of 756,800 shares, which accounts for 0.26% of the circulating shares [2] - The estimated floating profit for the Southern CSI 1000 ETF today is approximately 2.119 million CNY. The fund was established on September 29, 2016, with a latest scale of 64.953 billion CNY. Year-to-date returns are 28.58%, ranking 2093 out of 4221 in its category; the one-year return is 34.04%, ranking 1521 out of 3848; and the return since inception is 13.79% [2]
大博医疗股价涨5%,南方基金旗下1只基金位居十大流通股东,持有75.68万股浮盈赚取211.9万元